Home
News
Editorial
MD(e)B(unker)
Related Researches
Di Bella's Foundation
1960-1969
1970-1979
1980-1989
1990-1999
2000-2009
2010-2019
2020-2029
Science news
Scientific Documentation
About us...
Biography
Bibliography
The Method
Di Bella's Method!
1998 Trial!
Media
Video Publications
News-Papers
Press
Testimonial
Testimonies
Video Gallery
Congresses
Video Testimonies
TV & C.
Case History
Lung
Lymphomas
Non-Hodgkin Lymphomas
Hodgkin Lymphomas
Mediastinum
Mesothelioma
Myeloma
Pancreas
Scientific Publications
F.A.Q.
Useful Links
User Side
Vademecum
CouponChief - Resources for Cancer Patients
Contact Us
Home page
News
Related Researches
1990-1999
Title
Created Date
A randomized study with the pineal hormone melatonin versus supportive care alone in patients with brain metastases due to solid neoplasms
11 November 2014
A randomised study with subcutaneous low-dose interleukin 2 alone vs interleukin 2 plus the pineal neurohormone melatonin in advanced solid neoplasms other than renal cancer and melanoma
11 November 2014
Decreased toxicity and increased efficacy of cancer chemotherapy using the pineal hormone melatonin in metastatic solid tumour patients with poor clinical status
10 November 2014
A randomized study of chemotherapy with cisplatin plus etoposide versus chemoendocrine therapy with cisplatin, etoposide and the pineal hormone melatonin as a first-line treatment of advanced non-small cell lung cancer patients in a poor clinical state
10 November 2014
All-trans retinoic acid in relapsing malignant gliomas: clinical and radiological stabilization associated with the appearance of intratumoral calcifications
03 November 2014
Retinoids in pancreatic cancer
28 August 2014
Molecular analysis of the somatostatin receptor subtype 2 in human glioma cells
14 August 2014
Human somatostatin receptor mediated antiproliferative action evokes subtype selective cytotoxic and cytostatic signaling
12 August 2014
Time-dependent influence of the somatostatin analogue octreotide on the proliferation of rat astrocytes and glioma cells
05 August 2014
Effect of the gastrin-releasing peptide antagonist BIM 26226 and lanreotide on an acinar pancreatic carcinoma
05 August 2014
Display #
5
10
15
20
25
30
50
100
All
Page 50 of 60
Start
Prev
45
46
47
48
49
50
51
52
53
54
Next
End
Search
Follow us...
Latest
Melatonin, an inhibitory agent in breast cancer
Melatonin: an inhibitor of breast cancer
Therapeutic treatments potentially mediated by melatonin receptors: potential clinical uses in the prevention of osteoporosis, cancer and as an adjuvant therapy
Differential expression of high-affinity melatonin receptors (MT1) in normal and malignant human breast tissue
In Vitro Investigations on the Antioxidant Effects of Vitamin D in a Panel of Cancer Cell Lines
Melatonin Inhibits Gastric Cancer Cell Proliferation by Suppressing Exosome miR-27b-3p Expression
Vitamin D deficiency as a risk factor for thyroid cancer: A meta-analysis of case-control studies
Melatonin and its therapeutic prospects in gastroenterology
Catecholamines Mediate Psychologic Stress-Induced Cancer Progression
Psychologic Stress Drives Progression of Malignant Tumors via DRD2/HIF1α Signaling
Melatonin Alleviates Acute Respiratory Distress Syndrome by Inhibiting Alveolar Macrophage NLRP3 Inflammasomes Through the ROS/HIF-1α/GLUT1 Pathway
The potential therapeutic effect of melatonin on human ovarian cancer by inhibition of invasion and migration of cancer stem cells
Melatonin Supplementation Improves Pain, Sleep Quality, and Total Plasma Antioxidant Capacity in Women with Fibrocystic Breast Disease: A Randomized, Double-blind, Placebo-controlled Trial
Melatonin as antioxidant, geroprotector and anticarcinogen
Pretreatment with melatonin protects against cyclophosphamide-induced oxidative stress and renal damage in mice
The role of calcium and vitamin D dietary intake on risk of colorectal cancer: systematic review and meta-analysis of case-control studies
SSTR2-targeting therapy in EBV-positive and EBV-negative metastatic nasopharyngeal carcinoma
Melatonin Represses Metastasis in Her2-Postive Human Breast Cancer Cells by Suppressing RSK2 Expression
Most Read
The Di Bella Method (DBM)
About melatonin - 1996
All-trans-retinoic acid and cancer
Biography
The Di Bella Method Increases by the 30% the survival rate for Pancreas tumors and for this reason should be proposed as first line therapy for this type of cancer
Chronic Lymphocytic Leukemia: 4 patients, long-lasting remission
Somatostatin in oncology, the overlooked evidences
Treatment of Low-grade Non-Hodgkin’s Lymphomas at Advanced Stage
How effective is chemo therapy?
Bibliography
Complete objective response to biological therapy of plurifocal breast carcinoma
Large B-cells Non-Hodgkin's Lymphoma, Stage IV-AE: a Case Report
Non-Hodgkin's Lymphoma, Stage III-B-E: a Case Report
Vademecum
Frequently Asked Questions
Declaration recommends eliminate the use of Impact factor for research evaluation
Non–Small-Cell Lung Cancer Patients with Low Performance Status: study on 28 patients
Breast cancer: study on 122 cases. The Di Bella Method (DBM) improved survival, objective response and performance status in a retrospective observational clinical study on 122 cases of breast cancer